BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19856028)

  • 1. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.
    Chua TC; Saxena A; Liauw W; Kokandi A; Morris DL
    Ann Surg Oncol; 2010 Feb; 17(2):492-501. PubMed ID: 19856028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Sabanathan D; Eslick GD; Shannon J
    Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.
    Lam VW; Spiro C; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
    Ann Surg Oncol; 2012 Apr; 19(4):1292-301. PubMed ID: 21922338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
    Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
    Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
    World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.
    Brouquet A; Nordlinger B
    J Surg Oncol; 2010 Dec; 102(8):932-6. PubMed ID: 21165995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
    Ayez N; van der Stok EP; de Wilt H; Radema SA; van Hillegersberg R; Roumen RM; Vreugdenhil G; Tanis PJ; Punt CJ; Dejong CH; Jansen RL; Verheul HM; de Jong KP; Hospers GA; Klaase JM; Legdeur MC; van Meerten E; Eskens FA; van der Meer N; van der Holt B; Verhoef C; Grünhagen DJ
    BMC Cancer; 2015 Mar; 15():180. PubMed ID: 25884448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy with curative intent before (neoadjuvant) or after (adjuvant) surgery for colorectal cancer liver metastases].
    Rougier P; Guimbaud R; Mitry E; Vaillant JN
    Bull Acad Natl Med; 2003; 187(5):881-92. PubMed ID: 14979053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.
    Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
    Oncotarget; 2016 Jun; 7(24):37277-37287. PubMed ID: 27074564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials.
    Wang P; Chen Z; Huang WX; Liu LM
    World J Gastroenterol; 2005 Jul; 11(25):3817-22. PubMed ID: 15991275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
    Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
    Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.
    Hebbar M; Pruvot FR; Romano O; Triboulet JP; de Gramont A
    Cancer Treat Rev; 2009 Dec; 35(8):668-75. PubMed ID: 19733977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.
    Bathe OF; Dowden S; Sutherland F; Dixon E; Butts C; Bigam D; Walley B; Ruether D; Ernst S
    BMC Cancer; 2004 Jul; 4():32. PubMed ID: 15245580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases.
    Lam VW; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
    HPB (Oxford); 2013 Jul; 15(7):483-91. PubMed ID: 23750490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.